Related references
Note: Only part of the references are listed.The Inflammatory and Fibrotic Patterns of Hepatic Stellate Cells Following Coagulation Factors (VII or X)-Shielded Adenovirus Infection
Alireza Shiri et al.
CURRENT MICROBIOLOGY (2021)
Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?
Robert A. Campbell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie J. Ewer et al.
NATURE MEDICINE (2021)
Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46
B. David Persson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection
Giuseppe Cappellano et al.
CELLS (2021)
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination
Eun-Ju Lee et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
High prevalence of occult thrombosis in cases of mild/moderate COVID-19
Budong Chen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies
Justine Brodard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Thrombocytopenia in Virus Infections
Matthijs Raadsen et al.
JOURNAL OF CLINICAL MEDICINE (2021)
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
Isaac See et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Diverse functional autoantibodies in patients with COVID-19
Eric Y. Wang et al.
NATURE (2021)
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Marie Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Kate-Lynn Muir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Nina H. Schultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia
Douglas B. Cines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Andreas Greinacher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription
Abdulaziz Almuqrin et al.
GENOME MEDICINE (2021)
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
C. R. Simpson et al.
NATURE MEDICINE (2021)
COVID-19-associated immune thrombocytopenia
Gienke Bomhof et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Hemostatic laboratory derangements in COVID-19 with a focus on platelet count
Ariunzaya Amgalan et al.
PLATELETS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Lynda Coughlan
FRONTIERS IN IMMUNOLOGY (2020)
Venous thromboembolism in non-critically ill patients with COVID-19 infection
Antonin Trimalle et al.
THROMBOSIS RESEARCH (2020)
Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19
Zheng Cai et al.
ANTIBODIES (2020)
The unique characteristics of COVID-19 coagulopathy
Toshiaki Iba et al.
CRITICAL CARE (2020)
Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting
Jiansong Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya
Gaudensia Mutua et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome
Elan Mohanty et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions
Alexander T. Baker et al.
NATURE COMMUNICATIONS (2019)
Sialic Acid-Containing Glycans as Cellular Receptors for Ocular Human Adenoviruses: Implications for Tropism and Treatment
Naresh Chandra et al.
VIRUSES-BASEL (2019)
Regulatory T Cells Control PF4/Heparin Antibody Production in Mice
Yongwei Zheng et al.
JOURNAL OF IMMUNOLOGY (2019)
Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor
Alexander T. Baker et al.
SCIENCE ADVANCES (2019)
Ebola vaccine trials: progress in vaccine safety and immunogenicity
Keesha M. Matz et al.
EXPERT REVIEW OF VACCINES (2019)
αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26
Davor Nestic et al.
JOURNAL OF VIROLOGY (2019)
Are adenoviruses zoonotic? A systematic review of the evidence
Laura K. Borkenhagen et al.
EMERGING MICROBES & INFECTIONS (2019)
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Carly M. Bliss et al.
SCIENTIFIC REPORTS (2018)
Autoimmune heparin-induced thrombocytopenia
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity
Thi-Huong Nguyen et al.
NATURE COMMUNICATIONS (2017)
The unique immunological features of heparin-induced thrombocytopenia
Phillip Staibano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Simian adenoviruses as vaccine vectors
Susan J. Morris et al.
FUTURE VIROLOGY (2016)
Immune pathogenesis of heparin-induced thrombocytopenia
Sanjay Khandelwal et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials
Hela Kallel et al.
BIOTECHNOLOGY JOURNAL (2015)
Critical role of CD4 T cells in PF4/heparin antibody production in mice
Yongwei Zheng et al.
BLOOD (2015)
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
Matthew D. J. Dicks et al.
SCIENTIFIC REPORTS (2015)
Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials
Hela Kallel et al.
BIOTECHNOLOGY JOURNAL (2015)
Adenovirus type 3 induces platelet activation in vitro
Ying-Yu Jin et al.
MOLECULAR MEDICINE REPORTS (2014)
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
Platelets and infection - an emerging role of platelets in viral infection
Alice Assinger
FRONTIERS IN IMMUNOLOGY (2014)
Coagulation Factor Binding Orientation and Dimerization May Influence Infectivity of Adenovirus-Coagulation Factor Complexes
Eric E. Irons et al.
JOURNAL OF VIROLOGY (2013)
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
Marc Gurwith et al.
LANCET INFECTIOUS DISEASES (2013)
Platelet-adenovirus vs. inert particles interaction: Effect on aggregation and the role of platelet membrane receptors
Elena Gupalo et al.
PLATELETS (2013)
Sexual Risk Behaviors, Circumcision Status, and Preexisting Immunity to Adenovirus Type 5 Among Men Who Have Sex With Men Participating in a Randomized HIV-1 Vaccine Efficacy Trial: Step Study
Beryl A. Koblin et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
Hualin Li et al.
JOURNAL OF VIROLOGY (2012)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments
Sophie Escutenaire et al.
ANNALS OF MEDICINE (2011)
The STEP-Wise Future of Adenovirus-Based HIV Vaccines
L. J. Patterson
CURRENT MEDICINAL CHEMISTRY (2011)
A Cluster of Basic Amino Acids in the Factor X Serine Protease Mediates Surface Attachment of Adenovirus/FX Complexes
Margaret R. Duffy et al.
JOURNAL OF VIROLOGY (2011)
Human platelets express CAR with localization at the sites of intercellular interaction
Elena Gupalo et al.
VIROLOGY JOURNAL (2011)
Cross-Species Transmission of a Novel Adenovirus Associated with a Fulminant Pneumonia Outbreak in a New World Monkey Colony
Eunice C. Chen et al.
PLOS PATHOGENS (2011)
Delivery of antigens by viral vectors for vaccination
Anja Krause et al.
THERAPEUTIC DELIVERY (2011)
Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
Raul Alba et al.
BLOOD (2010)
Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
Angela C. Bradshaw et al.
PLOS PATHOGENS (2010)
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
Robert C. Carlisle et al.
BLOOD (2009)
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
Raul Alba et al.
BLOOD (2009)
Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer
Alan L. Parker et al.
JOURNAL OF VIROLOGY (2009)
A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
David I. Watkins et al.
NATURE MEDICINE (2008)
Adenovirus serotype 5 hexon is critical for virus infection of heptocytes in vivo
O. Kalyuzhniy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver
Daniel Stone et al.
JOURNAL OF VIROLOGY (2007)
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance
Maha Othman et al.
BLOOD (2007)
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Alan L. Parker et al.
BLOOD (2006)
Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice
AN Varnavski et al.
GENE THERAPY (2005)
Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-Ad antibodies
H Jiang et al.
MOLECULAR THERAPY (2004)
Toxicity of a first-generation adenoviral vector in rhesus Macaques
JN Lozier et al.
HUMAN GENE THERAPY (2002)
A journey with platelet P-selectin: The molecular basis of granule secretion, signalling and cell adhesion
B Furie et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment
TP Baglin
JOURNAL OF CLINICAL PATHOLOGY (2001)
Identification of T cells responding to a self-protein modified by an external agent
S Bacsi et al.
HUMAN IMMUNOLOGY (2001)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus
TA Martino et al.
VIROLOGY (2000)
Share Paper
